Blood tests for Alzheimer’s disease are currently available
Title:
Blood tests for Alzheimer’s disease are currently available
Description:
The experts from the US FDA say that oral decongestant pills with phenylephrine (called PE) do not work well for stuffy noses because they break down before getting into your body. They want to change how these pills are labeled to stop people from being misled. This might make companies change their products. A group that represents these companies is worried about this. But scientists and researchers are happy about the findings. In 2022, PE pills made $1.76 billion in the US, while better options like pseudoephedrine (called PSE) made $542 million. It's important to educate consumers so they can choose the right alternatives. Contact us - 44(782)-201-3567 (UK) +1(646)631-6696 (USA) +91-904-002-3003 (India) Website - – PowerPoint PPT presentation
Number of Views:0
Title: Blood tests for Alzheimer’s disease are currently available
1
Blood tests for Alzheimers disease are currently
available
2
(No Transcript)
3
- Alzheimers disease, affecting 55 million
globally with no cure, sees recent progress in
drugs to slow its progression. Early intervention
with these drugs is crucial, but current
diagnostic methods often miss early signs.
Evidence suggests Alzheimers indicators can be
detected in the blood up to two decades prior to
symptoms. Several US companies offer Alzheimers
blood tests for consumers, analyzing amyloid-beta
proteins. While these tests show promise, caution
is advised in interpreting results. They detect
only one Alzheimers biomarker and may not
account for diverse backgrounds or health
conditions. Researchers explore tau protein tests
and multi-marker approaches, indicating potential
improvements in Alzheimers diagnosis accuracy.
Recommended
CrystalGraphics Presentations
